Starting antiretroviral therapy early essential to battling not one, but two killers
Initial COVID-19 infection on the single-cell level, revealed
Zika vaccine shows promising results in preclinical studies
Texas Biomed breaks ground on new Animal Care Complex
Compound shows promise for minimizing erratic movements in Parkinson’s patients
Pumpkins and Primates: Celebrating the unsung heroes of biomedical research
Tuberculosis expert Smriti Mehra, Ph.D., joins Texas Biomed faculty
Southwest National Primate Research Center at Texas Biomed receives $37 million NIH grant
Texas BioMed part of team granted millions to find a cure for AIDS
NIH establishes center to end HIV/AIDS in Texas
NIH Funds Texas Institutes of Health for HIV Research
Texas Biomed shares critical work in development of Pfizer COVID-19 vaccine
TB study reveals potential targets to treat and control infection using cutting-edge technology
Texas Biomed veterinarian receives high honor from the National Institutes of Health
Texas Biomed eyes more deals from its Covid work for Pfizer
Results of comprehensive SARS-CoV-2 animal model study published in Nature Microbiology
As Nobel Prizes are awarded, Texas Biomed celebrates contributions to winning research on hepatitis C
Global foundation awards Texas Biomed $1 million to conduct large-scale rodent testing of human monoclonal antibodies to combat SARS-CoV-2
Texas Biomed to build new animal research facility as part of 10-year strategic plan
Pfizer, Texas Biomed see promising results in prototype vaccine